Nasdaq:US$15.69 (+0.28) | HKEX:HK$25.40 (+0.50) | AIM:£2.21 (-0.02)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 13 Jul 2009

Phase II Crohn’s Disease Trial for HMPL-004 Delivers Encouraging Results

1 items
a090713